Other
Today, Merck's cholesterol-lowering drug Zocor loses its United States patent protection, becoming the largest-selling drug yet to be opened to cheap generic competition. |
Common side effects include constipation, headaches, and nausea. Hepatic CYP3A4. |
The NHS is to launch a mass trial of an as-yet unapproved twice-yearly cholesterol-lowering injection, which it hopes will save lives and cut medical bills for thousands of people who do not take statins. The NHS has struck a novel deal with drugmaker Novartis, which will provide the injections free in exchange for the results of the five-year trial, which will be run by the NHS staff. |
Controlled Substance. |
Merck lost patent protection on Zocor. |
Golden Jubilee Celebrations. |
Please Note: This product has been discontinued by the manufacturer. |
The items in your order may be shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. |
Error: This is required. Error: Not a valid value. |
Controlled Substance. |









